You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 6, August 10, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Health Policy
 •Medical Ethics
 •Alert me on articles by topic

Disclosing Individual Results of Clinical Research

Implications of Respect for Participants

David I. Shalowitz, AB; Franklin G. Miller, PhD

JAMA. 2005;294:737-740.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Controversy exists about the responsibility of investigators to communicate the results of research to study participants. These research results may be categorized as either general study results, which represent aggregate data usually published by the research team, or individual results, which are research findings relevant to particular participants. Disclosure of individual research results has become particularly contentious in the context of genetics research, for which genotypes of individual participants often become known to investigators.1 However, disclosure of individual results should be addressed in all research involving human participants.

When aggregate results of research correlate with aspects of the health and well-being of participants, disclosing individual results has the potential to significantly affect the lives of participants. Accordingly, investigators and institutional review boards (IRBs) should consider when and how participants should be informed of individual research results. This article reviews previously articulated policies . . . [Full Text of this Article]

Existing Standards

Author Affiliations: Department of Clinical Bioethics, National Institutes of Health, Bethesda, Md.


RELATED LETTERS

Implications of Disclosing Individual Results of Clinical Research
Ellen Wright Clayton and Lainie Friedman Ross
JAMA. 2006;295(1):37.
EXTRACT | FULL TEXT  

Implications of Disclosing Individual Results of Clinical Research—Reply
David I. Shalowitz and Franklin G. Miller
JAMA. 2006;295(1):37-38.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Duty to disclose what? Querying the putative obligation to return research results to participants
Miller et al.
J. Med. Ethics 2008;34:210-213.
ABSTRACT | FULL TEXT  

Patients need not give consent in all clinical education.
Dinnett et al.
BMJ 2006;332:549-549.
FULL TEXT  

Offering results to research participants
MacNeil and Fernandez
BMJ 2006;332:188-189.
FULL TEXT  

Implications of Disclosing Individual Results of Clinical Research
Clayton and Ross
JAMA 2006;295:37-37.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.